Back to PollNow

Back to companies

RenovoRx, Inc.

RNXTUSNASDAQPharmaceuticals & Healthcare

RenovoRx, Inc.

Revenue

$1.1mn

YoY +2511.6%

Operating income

-$12.5mn

FY2025

Employees

—

Founded

—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API